Picture EBD Group BIO-Europe 2023 Munich BEU23 650x100px

Document › Details

Compugen Ltd.. (2/15/17). "Press Release: Compugen Reports Fourth Quarter and Calendar Year 2016 Results". Holon.

	Organisation	Compugen Ltd. (Nasdaq: CGEN)
	Group	Compugen (Group)
	Organisation 2	Bayer (Group)
	Product	bioinformatics (biological software and databases)
	Product 2	drug discovery
	Person	Cohen-Dayag, Anat (Compugen 201112 CEO)
	Person 2	Gerstel, Martin (Compugen 200511–201710 Chairman RETIRED 10/17)

Original document
accessed by [iito] on 2017-02-16

Record changed: 2023-06-05

Picture EBD Group Startup Spotlight at BIO-Europe 2023 650x200px

More documents for Compugen (Group)

[1] Dotmatics Ltd.. (3/3/21). "Press Release: Dotmatics Announces Licensing Agreement for Informatics Software with Compugen". Bishop’s Stortford....
[2] Compugen Ltd.. (11/13/18). "Press Release: Compugen Announces Issuance of U.S. Patent for COM902, Its TIGIT Antibody Product Candidate for Cancer Immunotherapy". Holon....
[3] Compugen Ltd.. (11/7/18). "Press Release: Compugen Reports Third Quarter 2018 Results". Holon....
[4] Compugen Ltd.. (4/2/18). "Press Release: Compugen Announces Exclusive License Agreement with MedImmune for the Development of Bi-specific and Multi-specific Antibody Products". Holon....
[5] Compugen Ltd.. (3/26/18). "Press Release: Compugen Announces Appointment of Henry Adewoye, MD, as Chief Medical Officer". Holon....
[6] Compugen Ltd.. (3/8/18). "Press Release: Compugen to Present at the Cowen and Company 38th Annual Health Care Conference". Holon....
[7] Selexis S.A.. (3/7/18). "Press Release: Compugen Has Licensed Selexis’ Cell Line-Based Protein Expression Platform for the Development of Antibody-Based Therapeutics". Geneva....
[8] Compugen Ltd.. (11/7/17). "Press Release: Compugen Reports Third Quarter 2017 Results". Holon....
[9] Compugen Ltd.. (11/6/17). "Press Release: Compugen to Initiate Manufacturing of COM902, Its Lead antiTIGIT Monoclonal Antibody". Holon....
[10] Compugen Ltd.. (11/2/17). "Press Release: Compugen to Enter Research Collaboration with Mount Sinai on Novel Myeloid Immuno-Oncology Targets". Holon....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]